These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 22716463)

  • 1. Effect of antioxidants on captopril floating matrices.
    Jiménez-Martínez I; Domínguez-Ramírez AM; Villafuerte-Robles L
    Pharm Dev Technol; 2010 Jun; 15(3):230-40. PubMed ID: 22716463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antioxidants on captopril floating matrices.
    Jiménez-Martínez I; Domínguez-Ramírez AM; Villafuerte-Robles L
    Pharm Dev Technol; 2009 Jul; ():. PubMed ID: 19624250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets.
    Gutiérrez-Sánchez PE; Hernández-León A; Villafuerte-Robles L
    Drug Dev Ind Pharm; 2008 Feb; 34(2):171-80. PubMed ID: 18302036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets.
    Tapia-Albarran M; Villafuerte-Robles L
    Drug Dev Ind Pharm; 2004 Sep; 30(8):901-8. PubMed ID: 15521335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of bilayer floating tablets of captopril.
    Rahman Z; Ali M; Khar R
    Acta Pharm; 2006 Mar; 56(1):49-57. PubMed ID: 16613734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
    Chansanroj K; Betz G
    Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of captopril loaded gastro-retentive zein based porous floating tablets.
    Raza A; Hayat U; Wang HJ; Wang JY
    Int J Pharm; 2020 Apr; 579():119185. PubMed ID: 32112929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of added Pharmatose DCL11 on the sustained-release of metronidazole from Methocel K4M and Carbopol 971P NF floating matrices.
    Cedillo-Ramírez E; Villafuerte-Robles L; Hernández-León A
    Drug Dev Ind Pharm; 2006 Sep; 32(8):955-65. PubMed ID: 16954108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression.
    Saurí J; Millán D; Suñé-Negre JM; Pérez-Lozano P; Sarrate R; Fàbregas A; Carrillo C; Miñarro M; Ticó JR; García-Montoya E
    Int J Pharm; 2014 Jan; 461(1-2):38-45. PubMed ID: 24284019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compression and compaction properties of plasticised high molecular weight hydroxypropylmethylcellulose (HPMC) as a hydrophilic matrix carrier.
    Hardy IJ; Cook WG; Melia CD
    Int J Pharm; 2006 Mar; 311(1-2):26-32. PubMed ID: 16431049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.
    Asnaashari S; Khoei NS; Zarrintan MH; Adibkia K; Javadzadeh Y
    Pharm Dev Technol; 2011 Aug; 16(4):400-7. PubMed ID: 20429828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-in vivo correlation and bioavailability studies of captopril from novel controlled release donut shaped tablet.
    Mandal AS; Chatterjee S; Kundu S; Biswas N; Guha A; Paul S; Kuotsu K
    Int J Pharm; 2011 Dec; 421(1):145-50. PubMed ID: 21945741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
    Al-Taani BM; Tashtoush BM
    AAPS PharmSciTech; 2003; 4(3):E43. PubMed ID: 14621975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaceutical technology of Tensiomin].
    Fekete P
    Acta Pharm Hung; 1997 Jul; 67(4):113-21. PubMed ID: 9289939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.